USPTO serial 98812458
FIND YOUR HAPPINESS
Reviewed by CopyMark Law Group
Status 730Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- BARQUET-HORNBACK, ELENA M
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with FIND YOUR HAPPINESS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $648*
Plus Government fees of $300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Zurich, CH
Zurich, CH
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Vivian Ortiz-Ponce
Vivian Ortiz-Ponce PEREZ GUERRERO LLCP.O. Box 9024163San Juan, PR 00902-4163United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products for use in the treatment of metabolic syndrome, obesity and overweight; preparations for medical and veterinary use for use in the treatment of metabolic syndrome, obesity and overweight; hygienic products in the nature of disinfectants and sanitary preparations for medical use in the treatment of metabolic syndrome, obesity and overweight; dietetic food and beverages adapted for medical or veterinary use for use in the treatment of metabolic syndrome, obesity and overweight; food supplements for persons or animals; capsules for medicines, sold empty for pharmaceuticals; medicines for constipation, dragées being medicated confectionery, for use in the treatment of metabolic syndrome, obesity and overweight; non-steroidal anti-inflammatory medicines for use in the treatment of metabolic syndrome, obesity and overweight; anti-fungal medicines; anti-malarial medicines; anti-pyretic medicines; Medicated soap for perspiration; anti-tumor medicines; antitussive medicines; cytostatic medicines for medical use; allergy medicines; diarrhea medicines; non-prescription medicines for use in the treatment of metabolic syndrome, obesity and overweight; medicines for adjusting the menstrual cycle; medicine for alleviating allergies; medicines for alleviating pain; acne medicines; medicines for alleviating burns; medicines for the treatment of gastrointestinal diseases; medicines for the prevention of puerperal fever; cough alleviating medicines; medicines for medical use for use in the treatment of metabolic syndrome, obesity and overweight; medicines for dental use for use in the treatment of metabolic syndrome, obesity and overweight; medicines for veterinary use for use in the treatment of metabolic syndrome, obesity and overweight serotherapeutic medicines; transdermal patch with medicine featuring preparations for the treatment of metabolic syndrome, obesity and overweight; patches impregnated with medicinal preparations for the treatment of metabolic syndrome, obesity and overweight; sulfonamide preparations; tonics, namely, medicinal drinks; medicines for alleviating constipation; diagnostic agents for pharmaceutical use for use in the treatment of metabolic syndrome, obesity and overweight; milk ferments for pharmaceutical use; mixed hormone preparations for pharmaceutical use for use in the treatment of metabolic syndrome, obesity and overweight; sunburn products for pharmaceutical use for treating sunburn; capsules for pharmaceutical use, sold empty for pharmaceuticals; tablets for pharmaceutical use, being capsules sold empty for pharmaceuticals; amino acid preparations for medical purposes; analgesics for pharmaceutical use; bacteriological preparations for medical and veterinary purposes; medicated body creams for medical use for use in the treatment of metabolic syndrome, obesity and overweight; medicated skincare preparations in the nature of body gels for medical use for use in the treatment of metabolic syndrome, obesity and overweight | ACTIVE | — |
| 009 | Downloadable mobile device applications for use in telemedicine, purchasing pharmaceutical products and creating medical content; Downloadable software applications for mobile telephones for use in telemedicine, purchasing pharmaceutical products and creating medical content; downloadable applications for use with mobile devices for use in telemedicine, purchasing pharmaceutical products and creating medical content; Downloadable software and applications for mobile devices for use in telemedicine, purchasing pharmaceutical products and creating medical content; downloadable mobile applications for use with portable computer devices for use in telemedicine, purchasing pharmaceutical products and creating medical content; downloadable mobile applications for use in information management; Downloadable computer application software for mobile phones for use in telemedicine, purchasing pharmaceutical products and creating medical content; downloadable software as a medical device for diagnosing and treating of metabolic syndrome, obesity and overweight in the field of telemedicine, and also for use in purchasing pharmaceutical products and creating medical content related thereto; Downloadable computer programs relating to the medical field for use in telemedicine, purchasing pharmaceutical products and creating medical content; scales | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 1, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 31, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 31, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 31, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 3, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 9, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 9, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 3, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 11, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 3, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 3, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 3, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 6, 2025 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Aug 6, 2025 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| May 6, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 6, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 6, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 23, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 23, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 23, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 23, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 22, 2025 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Apr 22, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 21, 2024 | NWAP | NEW APPLICATION ENTERED | — |